Director/PDMR Shareholding

RNS Number : 8547W
GlaxoSmithKline PLC
31 January 2013
 

 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in interests of the under-mentioned Person Discharging Managerial Responsibility in the Ordinary shares of GlaxoSmithKline plc ("Ordinary shares"):

 

Dr P Vallance

Following the vesting on 29 January 2013 of 25% of an award made on 29 January 2007 under the GlaxoSmithKline Deferred Investment Award Plan ("The Plan"), Dr Vallance will receive a cash payment of 1433.75p per share in respect of 4997.121 notional Ordinary shares on 20 February 2013.

 

The Company and the above-mentioned person were advised of this information by the Administrators of the Plan on 31 January 2013.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

31 January 2013

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQFLFXXFFLBBB

Companies

GSK (GSK)
UK 100

Latest directors dealings